Skip to main content
. 2021 Oct 5;11:19712. doi: 10.1038/s41598-021-99311-y

Table 2.

Response according to pretreatment sPD-L1 levels. Response was evaluated in 113 patients. The results are presented as total numbers (percentages).

ICI response Total p value*
CR, PR, SD PD
Low sPD-L1 46 (79) 12 (21) 58 (100) 0.013
High sPD-L1 32 (58) 23 (42) 55 (100)
Total 78 35 113

sPD-L1 soluble programmed death ligand-1, ICI immune checkpoint inhibitor, CR complete response, PR partial response, SD stable disease, PD progressive disease.

*Significance at p < 0.05 (χ2 test).